Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP50241.RABUPaMkBalvEo99MU4UK-FvVwuQACphUpAuWZD3fOusA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP50241.RABUPaMkBalvEo99MU4UK-FvVwuQACphUpAuWZD3fOusA130_assertion type Assertion NP50241.RABUPaMkBalvEo99MU4UK-FvVwuQACphUpAuWZD3fOusA130_head.
- NP50241.RABUPaMkBalvEo99MU4UK-FvVwuQACphUpAuWZD3fOusA130_assertion description "[In contrast, the TNF promoter variants TNF2 (-238A) and TNF3 (-308A) conferred a 3.2-fold and 5.1-fold risk of cirrhosis respectively (P = 0.03 for both).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50241.RABUPaMkBalvEo99MU4UK-FvVwuQACphUpAuWZD3fOusA130_provenance.
- NP50241.RABUPaMkBalvEo99MU4UK-FvVwuQACphUpAuWZD3fOusA130_assertion evidence source_evidence_literature NP50241.RABUPaMkBalvEo99MU4UK-FvVwuQACphUpAuWZD3fOusA130_provenance.
- NP50241.RABUPaMkBalvEo99MU4UK-FvVwuQACphUpAuWZD3fOusA130_assertion SIO_000772 11196686 NP50241.RABUPaMkBalvEo99MU4UK-FvVwuQACphUpAuWZD3fOusA130_provenance.
- NP50241.RABUPaMkBalvEo99MU4UK-FvVwuQACphUpAuWZD3fOusA130_assertion wasDerivedFrom gad-20130706 NP50241.RABUPaMkBalvEo99MU4UK-FvVwuQACphUpAuWZD3fOusA130_provenance.
- NP50241.RABUPaMkBalvEo99MU4UK-FvVwuQACphUpAuWZD3fOusA130_assertion wasGeneratedBy ECO_0000203 NP50241.RABUPaMkBalvEo99MU4UK-FvVwuQACphUpAuWZD3fOusA130_provenance.